Pressmeddelande -
Natural Cycles and Merck collaborate on Digitalization and Fertility Awareness
- Digitalization offers new ways of delivering healthcare
Stockholm, Sweden, April 21st, 2016 – Merck, a leading science and technology company, today announced that Natural Cycles AB and Merck AB, the subsidiary in Sweden of the Merck group, are joining forces to generate new knowledge on how the increased use of digital tools in society will affect how women relate to their bodies and connect to their natural reproduction cycles.
Digitalization is rapidly changing the world, industries and sectors. The intimacy of the smartphone is also changing how we relate to our bodies and how healthcare is delivered. “We saw that there was limited knowledge among the stakeholders on how the increased use of digital tools like Natural Cycles will impact how women over time build knowledge of their natural biological rhythms. We are proud to collaborate with Merck, starting in Sweden. Merck has a long legacy in fertility awareness and combine competences in biology and new technologies.” says Elina Berglund-Scherwitzl, CTO and co-founder of Natural Cycles.
“Natural Cycles is an example on how digital medicine is poised to transform biomedical research and clinical practice. As a global science and technology company we are interested in how this group of clinically validated and rigorously tested technologies will impact society, healthcare and benefit patients. ” says Mats Berggren, who co-ordinates the digital health activities of Merck in Sweden.
The collaboration will generate new knowledge through a series of stakeholder meetings, discussion groups and generation of hypothesizes for future scientific research and development.
Ämnen
About Natural Cycles:
Natural Cycles was founded by husband and wife, Dr. Elina Berglund and Dr. Raoul Scherwitzl. With PhD’s in physics, they applied their mathematical techniques to developing the Natural Cycles algorithm. Elina was a researcher at CERN and was one of the physicists that discovered the Higgs Boson, which lead to the Nobel Prize in 2013. The Natural Cycles app was launched in August 2014 with a mission to educate and empower women to take control of their fertility and future around a vision where every pregnancy is wanted. Beyond the app offerings, the company advances scientific research in the field of contraception and fertility.
All Merck Press Releases are distributed by e-mail at the same time they become available on the Merck Website. Please go to www.merckgroup.com/subscribe to register online, change your selection or discontinue this service.
About Merck
Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2015, Merck generated sales of € 12.85 billion in 66 countries.
Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck, Darmstadt, Germany holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.
